LAUNCESTON MEDICAL CENTRE
LANDLAKE ROAD, LAUNCESTONHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 22 | 31 | 71.0% | |
HF 4 | 2011 | 20 | 30 | 66.7% | |
HF 4 | 2012 | 25 | 35 | 71.4% | |
HF 4 | 2013 | 30 | 37 | 81.1% | |
HF004 | 2014 | 3 | 3 | 100.0% | |
HF004 | 2015 | 6 | 6 | 100.0% | |
HF004 | 2016 | 5 | 5 | 100.0% | |
HF004 | 2017 | 34 | 37 | 91.9% | |
HF004 | 2018 | 51 | 63 | 81.0% | |
HF004 | 2019 | 61 | 65 | 93.8% | |
HF004 | 2020 | 60 | 71 | 84.5% | |
HF006 | 2021 | 63 | 80 | 78.8% | |
HF006 | 2022 | 120 | 123 | 97.6% | |
HF006 | 2023 | 122 | 149 | 81.9% |